References Overview Emond AM, Collis R, Darvill D, et al. Acute splenic sequestration in homozygous sickle cell disease: natural history and management. J Pediatr 1985 Aug;107(2): 201-6. Gilman PA, McFarlane JM, Huisman THJ. Natural history of sickle cell anemia: re-evaluation of a 15-year cord blood testing program [Abstract 452]. Pediatr Res 1976;10:376. National Sickle Cell Anemia Control Act of 1972, 42 U.S.C. § 201. Pearson HA, Gallagher D, Chilcote R, et al. Developmental pattern of splenic Scott RB. Health care priority and sickle cell anemia: special communication. Population To Be Screened Anyane-Yeboa K. Hemoglobinopathy screening during early pregnancy. Pediatrics 1989 May;83(5 Pt 2):881-3. Barnes MG, Komarmy L, Novack AH. A comprehensive screening program for hemoglobinopathies. JAMA 1972 Feb 7;219(6):701-5. Broghamer WL Jr, Lockwood WB, Keeling MM. Clinical assessment of three hemoglobin screening programs on a selected population. South Med J 1981 Dec;74(12):1443-6. Carr CM, Chapatwala KD. Sickle gene frequency in a Southcentral Alabama family medical program. Alabama Med 1988 Oct;58(4):17-8. Castro O, Winter WP, Lee TCK, et al. Prevalence of a-chain variants at birth. Am J Clin Pathol 1981 Jan;75(1):56-9. Diaz-Barrios V. New York's experience. Pediatrics 1989 May;83(5 Pt 2);872-5. Eddy DM, Hasselblad V. FAST*PRO software for meta-analysis by the confidence profile method. San Diego: Academic Press; 1992. Foster K, Forbes M, Hayes R, et al. Cord blood screening for sickle hemoglobin: evidence against a female preponderance of hemoglobin S. South J Pediatr 1981 Jan;98(1):79-81. Frame PS. A critical review of adult health maintenance, part 1: prevention of atherosclerotic diseases. J Fam Pract 1986;22:341. Gardner RV, Keitt A. University of Florida sickle cell screening program for neonates: design and results. J Natl Med Assoc 1988 Mar;80(3):273-9. Gaston MH, Verter JL, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial. N Engl J Med 1986;314:1593-9. Grover R, Wethers DL, Shahidi S, et al. Evaluation of the expanded newborn screening program in New York City. Pediatrics 1978;61:740-9. Harris MS, Eckman JR. Georgia's experience with newborn screening: 1981 to 1985. Pediatrics 1989 May;83(5 Pt 2):858-60. Huisman THJ, Harris HF, Stewart A, et al. The frequencies of Hbs S and C in Georgia and South Carolina. Hum Genet 1991;87:102-3. Lane PA, Mauro RD, Houston ML, et al. Universal neonatal screening for hemoglobinopathies is more cost-effective than screening targeted to high-risk infants [Abstract]. Presented at the Ninth National Neonatal Screening Symposium, Raleigh, NC, April 7-11, 1992. Lobel JS, Cameron BF, Johnson E, et al. Value of screening umbilical cord blood for hemoglobinopathy. Pediatrics 1989 May;83(5 Pt 2):823-6. Mack A. Florida's experience with newborn screening. Pediatrics 1989 May;83 (5 Pt 2):861-3. Meany FJ, Riggle SM. Newborn screening report, 1990. Austin (TX): Council of Regional Networks for Genetic Services; 1992. Pass KA, Gauvreau AF, Schedlbauer LM, et al. Newborn screening for sickle cell disease in New York State. In Carter TP, Wiley AM, editors. Genetic disease: screening and management. New York: AR Liss; 1986. p. 359-72. Pearson HA. The kidney, hepatobiliary system, and spleen in sickle cell anemia. Sickle cell disease. Ann NY Acad Sci 1989;565:120-5. Powars DR. Diagnosis at birth improves survival of children with sickle cell anemia. Pediatrics 1989;83(Suppl):830-3. Ralston KK, Kmetz DR, Keeling MM, et al. Screening for major hemoglobinopathies in newborn blacks. J Ky Med Assoc 1981 Oct;79(10):649-51. Schedlbauer LM, Pass KA. Cellulose acetate/citrate agar electrophoresis of filter paper hemolysates from heel stick. Pediatrics 1989 May;83(5 Pt 2):839-42. Sickle Cell Disease Guideline Panel. Sickle cell disease. Guideline report. AHCPR Pub. No. 93-0504. Rockville (MD): Agency for Health Care Policy and Research; in press. Sprinkle RH, Hynes DM, Konrad TR. A reconsideration of universal neonatal hemoglobinopathy screening in the United States; in press. Therrell BL, Simmank JL, Wilborn M. Experiences with sickle hemoglobin testing in the Texas newborn screening program. Pediatrics 1989 May;83(5 Pt 2);864-7. Tsevat JW, John B, Pauker SG, et al. Neonatal screening for sickle cell disease: a cost-effectiveness analysis. J Pediatr 1991 April;118(4 Pt 1):546-54. Vichinsky E, Hurst D, Earles A, et al. Newborn screening for sickle cell disease: effect on mortality. Pediatrics 1988 Jun;81(6):749-55. Wethers DL, Grover R. Screening the newborn for sickle cell disease: is it worth the effort. In: Carter TP, Wiley AM, eds, Genetic disease: screening and management. Proceedings of the 1985 Albany Birth Defects Symposium. New York: Alan R. Liss; 1986. p. 123-136. Laboratory Screening for Sickle Cell Disease Adam B, Bell C. Performance surveillance: sickle cell disease and other hemoglobinopathies. Infant Screening Quality Assurance Program 1992;2:1-8. Broghamer WL Jr, Lockwood WB, Keeling MM. Clinical assessment of three hemoglobin screening programs on a selected population. South Med J 1981 Dec;74(12):1443-6. Chan MS, Schneider NJ. Laboratory screening of hemoglobinopathies. Health Lab Sci 1975 Apr;12(2):91-9. Clinical Laboratories Improvement Amendments of 1988, 42 U.S.C. § 201. Descartes M, Huang Y, Zhang YH, et al. Direct genotypic analysis for sickle cell disease using DNA from newborn screening specimens: correlation with results from the state laboratory. Joint meeting of the American Pediatric Society for Pediatric Research, Anaheim CA, May 7-10, 1990. [Abstract] Pediatr Res 1990;27(4 part 2):130A. Fleiss JL. Statistical methods for rates and proportions. New York: Wiley; 1981. Galacteros F, Kleman K, Caburi-Martin J, et al. Cord blood screening for hemoglobin abnormalities by thin layer isoelectric focusing. Blood 1980;56: 1068-71. Gardner RV, Keitt A. University of Florida sickle cell screening program for neonates: design and results. J Natl Med Assoc 1988 Mar;80(3):273-9. Garrick M, Dembure P, Guthrie R. Sickle-cell anemia and other hemoglobinopathies: procedures and strategy for screening employing spots of blood on filter paper as specimens. N Engl J Med 1973 Jun;288(24):1265-8. Githens JH, Lane PA, McCurdy RS, et al. Newborn screening for hemoglobinopathies in Colorado. Am J Dis Child 1990 Apr;144(4):466-70. Griffiths PD, Mann JR, Darbyshire PJ, et al. Evaluation of eight and a half years of neonatal screening for hemoglobinopathies in Birmingham. BMJ [Clin Res Ed] 1988 Jun;296:1583-5. Hicks EJ, Hughes BJ. Comparison of electrophoresis on citrate agar, cellulose acetate, or starch for hemoglobin identification. Clin Chem 1975;21(8):1072-6. Huisman THJ. Usefulness of cation exchange high performance liquid chromatography as a testing procedure. Pediatrics 1989;83(Suppl):849-51. Huntsman RG, Metters JS, Yawson GI. The diagnosis of sickle cell disease in the newborn infant. J Pediatr 1972;80:279-81. Jacobs S, Peterson L, Thompson L, et al. Newborn screening for hemoglobin abnormalities. A comparison of methods. Am J Clin Pathol 1986;85:713-5. Kinney TR, Sawtschenko M, Whorton M, et al. Techniques' comparison and report of the North Carolina experience. Pediatrics 1989;83(Suppl):843-8. Kleman KM, Lorey FW, unpublished data, 1992. Kleman KM, Vichinsky E, Lubin BH. Experience with newborn screening using isoelectric focusing. Pediatrics 1989;83(Suppl):852-4. Kramer MS, Rooks Y, Johnston D, et al. Accuracy of cord blood screening for hemoglobinopathies. JAMA 1979;241:485-6. Lobel JS, Cameron BF, Johnson E, et al. Value of screening umbilical cord blood for hemoglobinopathy. Pediatrics 1989 May;83(5 Pt 2):823-6. McMahon L, unpublished data, 1992. Meany FJ, Riggle SM. Newborn screening report, 1990. Austin (TX): Council of Regional Networks for Genetic Services; 1992. Miller ST, Stilerman TV, Rao SP, et al. Newborn screening for sickle cell disease: when is an infant "lost to follow-up"? Am J Dis Child 1990 Dec;144(12):1343-5. National Committee for Clinical Laboratory Standards. Blood collection on filter paper for neonatal screening programs (NCCLS Doc. No. LA4-A). Villanova (PA): National Committee for Clinical Laboratory Standards; 1988. Pass KA, Gauvreau AF, Schedlbauer LM, et al. Newborn screening for sickle cell disease in New York State. In Carter TP, Wiley AM, editors. Genetic disease: screening and management. New York: AR Liss; 1986. p. 359-72. Rowley PT. Newborn screening for hemoglobinopathies. Semin Perinatol 1990 Dec;14:483-7. Schedlbauer LM, Pass KA. Cellulose acetate/citrate agar electrophoresis of filter paper hemolysates from heel stick. Pediatrics 1989 May;83(5 Pt 2):839-42. Schmidt RM, Brosius EM, Holland S, et al. Use of blood specimens collected on filter paper in screening for abnormal hemoglobin. Clin Chem 1976;22:685-7. Schroeder WA, Jakway J, Powars D. Detection of hemoglobin S and C at birth: a rapid screening procedure by column chromatography. J Lab Clin Med 1975;82:304-8. Steinberg MH, editor. Newborn screening for hemoglobinopathies: program development and laboratory methods. Bethesda (MD): National Heart, Lung, and Blood Institute; 1990. Therrell BL, Panny SR, Davidson A, et al. Newborn screening system guidelines. Statement of the Council of Regional Networks for Genetic Services. Austin (TX): Council of Regional Networks for Genetic Services; 1990. p. 1-10. Therrell BL, Pass KA, Hassemer D, et al. Laboratory techniques for neonatal hemoglobinopathy screening. Austin (TX): Texas Department of Health; 1990. Medical Management of Newborns and Infants with Sickle Cell Disease Adams T, McKie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992 Feb;326:605-10. Anglin DL, Siegel JD, Pacini DL. Effect of penicillin prophylaxis on nasopharyngeal colonization with Streptococcus pneumoniae in children with sickle cell anemia. J Pediatr 1984 Jan;104(1):18-22. Bainbridge R, Higgs DR, Maude GH, et al. Clinical presentation of homozygous sickle cell disease. J Pediatr 1985 Jun;106(6):881-5. Bakshi SS, Grover R, Cabezon E, et al. Febrile episodes in children with sickle cell disease treated on an ambulatory basis. J Assoc Acad Minor Phys 1991;2(2): 80-3. Belgrave FZ, Molock SD. The role of depression in hospital admissions and emergency treatment of patients with sickle cell disease. J Natl Med Assoc 1991 Sep;83(9):777-81. Brown AK, Miller ST, Agatisa P. Care of infants with sickle cell disease. Buchanan GR, Schiffman G. Antibody responses to polyvalent pneumococcal vaccine in infants with sickle cell anemia. J Pediatr 1980 Feb;96(2):264-6. Buchanan GR, Siegel JD, Smith SS, et al. Oral penicillin prophylaxis in children with impaired splenic function: a study of compliance. Pediatrics 1982 Dec;70(6): 926-30. Buchanan GR, Smith SJ. Pneumococcal septicemia despite pneumococcal vaccine and prescription of penicillin prophylaxis in children with sickle cell anemia. Am J Dis Child 1986 May;140(5):428-32. Centers for Disease Control. Risk associated with human parvovirus B19 infection. MMWR 1989;38:81-97. Chudwin DS, Wara DW, Matthay KK. Increased serum opsonic activity and antibody concentration in patients with sickle cell disease after pneumococcal polysaccharide immunization. J Pediatr 1983 Jan;102(1):51-4. Consensus Conference. Newborn screening for sickle cell disease and other hemoglobinopathies. JAMA 1987 Sep;258(9):1205-9. Cummins D, Heuschkel R, Davies SC. Penicillin prophylaxis in children with sickle cell disease in Brent study of physicians knowledge, patient compliance. BMJ 1991 Apr;302(6783):989-90. Davies SC, Brozovic M. The presentation, management, and prophylaxis of sickle cell disease. Blood Rev 1989;3:29. Day S, Brunson G, Wang W. A successful education program for parents of infants with newly diagnosed sickle cell disease. J Pediatr Nurs 1992;7(1):52-7. De Ceulaer K, McMullen KW, Maude GH, et al. Pneumonia in young children with homozygous sickle cell disease: risk and clinical features. Eur J Pediatr 1985 Sep;144(3):255-8. |